There is great geographical variation in the distribution of hepatocellular carcinoma (HCC),
with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one …

Purpose To compare the benefits and harms of radiofrequency ablation (RFA) and hepatic
resection (HR) and to test the consistency of currently available evidence. Materials and …

OBJECTIVES: Radiofrequency ablation (RFA) is widely performed for hepatocellular
carcinoma (HCC). However, there has been no report on 10-year outcome of RFA. The …

Purpose To compare radiofrequency ablation (RFA) with or without transcatheter arterial
chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC). Patients …

Background & Aims Both hepatic resection and radiofrequency ablation (RFA) are
considered curative treatments for hepatocellular carcinoma (HCC), but their economic …

Background & Aims The treatment of choice for early or moderately advanced hepatocellular
carcinoma (HCC) with good liver function remains controversial. We evaluated the …

Hepatocellular carcinoma (HCC) is a chronic liver disease that is highly fatal if not detected
and treated early. The incidence and death rate of HCC have been increasing in recent …

BACKGROUND & AIMS: The aim of this study was to compare liver resection and
radiofrequency ablation in patients with single hepatocellular carcinoma⩽ 3cm and …

Objective: To review the current status of radiofrequency ablation (RFA) in the management
of hepatocellular carcinoma (HCC). Summary Background Data: The development of local …

Hepatocellular carcinoma (HCC) represents a unique challenge for physicians and patients.
There is no definitively curative treatment. Rather, many treatment and management …